Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
American Journal of Clinical Oncology|April 1, 1994
Acute antiemetic efficacy and safety of dolasetron mesylate, a 5-HT3 antagonist, in cancer patients treated with cisplatin. European Dolasetron Study GroupT Conroy, P Cappelaere, M Fabbro, et al.
British Journal of Cancer|August 1, 1996
Serum neuron-specific enolase (S-NSE) and the prognosis in small-cell lung cancer (SCLC): a combined multivariable analysis on data from nine centresL G Jørgensen, K Osterlind, J Genollá, et al.
Oncology (Williston Park, N.Y.)|April 1, 1997
Cisplatin/paclitaxel vs cisplatin/teniposide for advanced non-small-cell lung cancer. The EORTC Lung Cancer Cooperative Group. The European Organization for Research and Treatment of CancerG Giaccone, P E Postmus, T A Splinter, et al.
European Journal of Cancer (Oxford, England : 1990)|February 21, 1998
No evidence of known types of human papillomavirus in squamous cell cancer of the oesophagus in a low-risk area. Rotterdam Oesophageal Tumour Study GroupT C Kok, K Nooter, S P Tjong-A-Hung, et al.
The Journal of Urology|March 1, 1992
The prognostic value of the pathological response to combination chemotherapy before cystectomy in patients with invasive bladder cancer. European Organization for Research on Treatment of Cancer--Genitourinary GroupT A Splinter, H I Scher, L Denis, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 2002
Results of a randomised phase II study of cisplatin plus 5-fluorouracil versus cisplatin plus 5-fluorouracil with alpha-interferon in metastatic pancreatic cancer: an EORTC gastrointestinal tract cancer group trialD J T Wagener, J A Wils, T C Kok, et al.
The Netherlands Journal of Medicine|August 1, 1995
Early detection and treatment of oesophageal and gastric cancer. The Rotterdam Oesophageal Tumour Study GroupP D Siersema, J Dees, H W Tilanus, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 1996
Standard versus alternating non-cross-resistant chemotherapy in extensive small cell lung cancer: an EORTC Phase III trialP E Postmus, G Scagliotti, H J Groen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Two schedules of teniposide with or without cisplatin in advanced non-small-cell lung cancer: a randomized study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative GroupT A Splinter, T Sahmoud, J Festen, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Comparison of two carboplatin-containing regimens with standard chemotherapy for small cell lung cancer in a randomised phase II study. The EORTC Lung Cancer Cooperative groupP E Postmus, T A Splinter, F M Palmen, et al.
Pageof 11